New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP

Breast cancer (BC) is the second leading cause of cancer death in women worldwide, and settings of specific prognostic factors and efficacious therapies are made difficult by phenotypic heterogeneity of BC subtypes. Therefore, there is a current urgent need to define novel predictive genetic predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Paolo, Antonov, Alexey, Anemona, Lucia, Vangapandou, Chaitania, Montanaro, Manuela, Botticelli, Andrea, Mauriello, Alessandro, Melino, Gerry, Catani, M. Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777524/
https://www.ncbi.nlm.nih.gov/pubmed/35201443
http://dx.doi.org/10.1007/s12672-021-00401-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777524/
https://www.ncbi.nlm.nih.gov/pubmed/35201443
http://dx.doi.org/10.1007/s12672-021-00401-0

Ejemplares similares